Dr. Ohsfeldt is a Scientific Advisor with Avalon Health Economics and an expert on health technology assessment and U.S. market access. Robert is a Professor in the Department of Health Policy and Management in the School of Rural Public Health at Texas A&M University, where he teaches courses in health economics and cost-effectiveness analysis. Previously, he was employed as a manager of health outcomes research for Eli Lilly and Company, where he received the President’s Award from Lilly Research Laboratories in 2001. Dr. Ohsfeldt completed his Ph.D. in economics at the University of Houston in 1983, and was a Robert Wood Johnson Foundation Fellow in Healthcare Finance at Johns Hopkins University and the Texas Medical Center during 1987-88. He is author or co-author of more than 100 papers published in peer-reviewed journals, and is a co-author of The Business of Health (2006). Dr. Ohsfeldt has been the principal investigator for research grants funded by the Agency for Healthcare Research and Quality, National Cancer Institute, Centers for Disease Control, and the Robert Wood Johnson Foundation. He has served as a peer-reviewer for more than 30 scientific journals, and has been a member of grant review panels for the National Institutes of Health, the Agency for Healthcare Research and Quality, and the Department of Veterans Affairs. Dr. Ohsfeldt currently serves as a member of the Editorial Board for the Journal of Managed Care Pharmacy.